TMO vs VRTV: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Veritiv Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
VS
Veritiv Corporation · Industrials
$169.99
-45.0% upside to fair value
Med Conviction
Grade D
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
VRTV |
| Current Price |
$658.32 |
$169.99 |
| Fair Value Estimate |
$863.34 |
$93.49 |
| Upside to Fair Value |
+31.1%
|
-45.0%
|
| Market Cap |
$244.7B |
$2.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
25.9x
|
5.4x
|
| Price / Sales |
5.3x
|
0.4x
|
| Price / FCF |
33.4x
|
10.4x
|
| Revenue Growth YoY |
+10.5%
|
-19.0%
|
| Gross Margin |
40.4%
|
22.7%
|
| Operating Margin |
17.7%
|
5.9%
|
| Return on Equity |
13.4%
|
48.6%
|
| Dividend Yield |
0.28% |
1.48% |
| FCF Yield |
3.0%
|
9.57%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
| Metric |
TMO |
VRTV |
| Zone Low |
$647.50 |
$70.12 |
| Zone High |
$733.84 |
$79.47 |
| In Buy Zone? |
Yes
|
No
|